Curis
CRIS
#11081
Rank
A$0.96 M
Marketcap
A$0.49
Share price
-17.89%
Change (1 day)
-80.39%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of March 2026 : A$1.9 Million

According to Curis's latest financial reports the company's total debt is A$1.9 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$2.41 M-49.14%
2024-12-31A$4.74 M15.81%
2023-12-31A$4.1 M-29.19%
2022-12-31A$5.79 M-16.69%
2021-12-31A$6.95 M-30.23%
2020-12-31A$9.96 M4102.74%
2019-12-31A$0.23 M-99.53%
2018-12-31A$50.36 M-5.37%
2017-12-31A$53.22 M93.19%
2016-12-31A$27.55 M-16.94%
2015-12-31A$33.17 M-4.07%
2014-12-31A$34.57 M0.94%
2013-12-31A$34.25 M19.3%
2012-12-31A$28.71 M
2008-12-31N/A-100%
2007-12-31A$0.46 M-81.61%
2006-12-31A$2.51 M-68.49%
2005-12-31A$7.97 M-9.97%
2004-12-31A$8.85 M16.34%
2003-12-31A$7.61 M-65.46%
2002-12-31A$22.03 M6.42%
2001-12-31A$20.7 M88.97%
2000-12-31A$10.95 M430.75%
1999-12-31A$2.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$90.71 B 4,766,541.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$66.08 B 3,472,450.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$41.05 M 2,057.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$0.24 B 12,580.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.71 M 42.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$12.11 M 536.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.81 B 42,802.02%๐Ÿ‡บ๐Ÿ‡ธ USA